Allogene Therapeutics (ALLO) Short Interest Ratio & Short Volume $2.09 +0.14 (+7.18%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Allogene Therapeutics Short Interest DataAllogene Therapeutics (ALLO) has a short interest of 31.17 million shares. This marks a -11.07% decrease in short interest from the previous month. The short interest ratio (days to cover) is 13.8, indicating that it would take 13.8 days of the average trading volume of 2.49 million shares to cover all short positions.Current Short Interest31,170,000 sharesPrevious Short Interest35,050,000 sharesChange Vs. Previous Month-11.07%Dollar Volume Sold Short$77.30 millionShort Interest Ratio13.8 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares209,672,000 sharesPercentage of Shares Shorted14.87%Today's Trading Volume1,810,945 sharesAverage Trading Volume2,487,045 sharesToday's Volume Vs. Average73% Short Selling Allogene Therapeutics? Sign up to receive the latest short interest report for Allogene Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALLO Short Interest Over TimeALLO Days to Cover Over TimeALLO Percentage of Float Shorted Over Time Ad Behind the Markets$19 for a FULL YEAR of stock picks?!We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $19. But why? Because there is a very small window of time... as little as 25 days from now... That will change the market forever.Click here to get in now>>> Allogene Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202431,170,000 shares $77.30 million -11.1%N/A13.8 $2.48 11/15/202435,050,000 shares $79.56 million -5.4%N/A16.2 $2.27 10/31/202437,040,000 shares $94.64 million -5.8%26.7%18.7 $2.56 10/15/202439,320,000 shares $106.56 million +2.1%28.5%21.7 $2.71 9/30/202438,510,000 shares $107.83 million -1.7%28.2%18.3 $2.80 9/15/202439,190,000 shares $116.00 million +0.6%28.7%17 $2.96 Get the Latest News and Ratings for ALLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202438,940,000 shares $102.41 million -0.7%28.5%15.8 $2.63 8/15/202439,230,000 shares $90.23 million +3.9%28.7%14.5 $2.30 7/31/202437,750,000 shares $110.99 million -12.7%27.6%12.9 $2.94 7/15/202443,230,000 shares $128.83 million +4.5%31.6%14.7 $2.98 6/30/202441,380,000 shares $96.42 million -4.4%30.3%15.3 $2.33 6/15/202443,280,000 shares $101.71 million +6.7%31.7%17.1 $2.35 5/31/202440,570,000 shares $101.43 million +11.4%33.5%16.2 $2.50 5/15/202436,430,000 shares $108.56 million +7.6%30.1%15.7 $2.98 4/30/202433,870,000 shares $93.48 million +8.0%32.0%15.5 $2.76 4/15/202431,360,000 shares $111.33 million +2.4%30.0%13.9 $3.55 3/31/202430,620,000 shares $136.87 million +10.3%29.3%11.7 $4.47 3/15/202427,750,000 shares $129.32 million +11.0%26.6%10 $4.66 2/29/202425,010,000 shares $122.80 million +6.7%24.1%8.3 $4.91 2/15/202423,450,000 shares $116.31 million +1.6%22.6%7.7 $4.96 1/31/202423,090,000 shares $81.28 million -23.6%22.2%7.4 $3.52 1/15/202430,210,000 shares $97.28 million -3.5%28.5%10.3 $3.22 12/31/202331,320,000 shares $100.54 million -6.7%29.6%11.9 $3.21 12/15/202333,550,000 shares $90.92 million +5.3%31.7%14.3 $2.71 11/30/202331,860,000 shares $74.87 million -1.5%30.1%16.8 $2.35 11/15/202332,340,000 shares $87.96 million -5.0%30.6%18.9 $2.72 10/31/202334,030,000 shares $95.96 million +10.7%32.2%22 $2.82 10/15/202330,730,000 shares $98.03 million -10.0%29.2%18 $3.19 9/30/202334,130,000 shares $108.19 million +2.1%32.2%19 $3.17 9/15/202333,420,000 shares $130.00 million +4.1%31.5%16.2 $3.89 8/31/202332,110,000 shares $124.91 million -2.0%30.3%12.4 $3.89 8/15/202332,770,000 shares $133.70 million -13.6%30.9%12.5 $4.08 7/31/202337,910,000 shares $188.03 million -8.1%39.4%14.3 $4.96 7/15/202341,260,000 shares $204.65 million +8.1%53.9%15.3 $4.96 6/30/202338,180,000 shares $189.75 million +1.7%49.9%14.1 $4.97 6/15/202337,560,000 shares $186.67 million -6.2%49.1%15.1 $4.97 5/31/202340,030,000 shares $210.16 million -1.4%52.1%20.4 $5.25 5/15/202340,590,000 shares $273.58 million -0.2%52.8%19.6 $6.74 4/30/202340,650,000 shares $220.73 million -1.4%53.3%20.3 $5.43 4/15/202341,220,000 shares $205.69 million +0.5%54.5%22.2 $4.99$19 for a FULL YEAR of stock picks?! (Ad)We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $19. But why? Because there is a very small window of time... as little as 25 days from now... That will change the market forever.Click here to get in now>>> 3/31/202341,010,000 shares $202.59 million +3.0%54.3%22.5 $4.94 3/15/202339,800,000 shares $225.27 million +8.0%49.6%20.9 $5.66 2/28/202336,860,000 shares $234.06 million +4.9%46.0%19.4 $6.35 2/15/202335,140,000 shares $254.06 million +2.1%44.0%18.4 $7.23 1/31/202334,410,000 shares $265.65 million +0.7%43.1%18 $7.72 1/15/202334,160,000 shares $241.17 million +2.2%42.7%18.1 $7.06 12/30/202233,430,000 shares $210.27 million +9.5%41.8%18 $6.29 12/15/202230,530,000 shares $216.15 million +0.2%38.2%16 $7.08 11/30/202230,470,000 shares $300.43 million -3.2%38.1%16.5 $9.86 11/15/202231,460,000 shares $311.45 million +1.6%39.3%18.2 $9.90 10/31/202230,960,000 shares $318.89 million +3.0%39.3%18.3 $10.30 10/15/202230,050,000 shares $305.91 million +8.9%38.3%18 $10.18 9/30/202227,590,000 shares $297.97 million +24.2%35.2%16 $10.80 9/15/202222,220,000 shares $311.08 million +0.9%28.3%12.8 $14.00 8/31/202222,020,000 shares $301.89 million -2.4%28.1%12 $13.71 8/15/202222,570,000 shares $390.01 million +0.8%28.8%11.6 $17.28 7/31/202222,400,000 shares $290.75 million -0.1%28.6%10.9 $12.98 7/15/202222,430,000 shares $287.33 million -0.3%28.6%10.2 $12.81 6/30/202222,490,000 shares $256.39 million +2.0%28.5%10.5 $11.40 6/15/202222,060,000 shares $212.22 million +9.5%28.0%10.8 $9.62 5/31/202220,150,000 shares $159.79 million +13.9%25.7%10.8 $7.93 5/15/202217,690,000 shares $127.90 million -0.4%22.5%9.6 $7.23 4/30/202217,760,000 shares $148.30 million -1.7%24.3%10.4 $8.35 4/15/202218,060,000 shares $149.00 million +18.6%24.8%11.4 $8.25 3/31/202215,230,000 shares $138.75 million +4.8%16.1%8.9 $9.11 3/15/202214,540,000 shares $113.41 million +18.7%19.8%8.6 $7.80 2/28/202212,250,000 shares $112.09 million +16.9%16.7%7.5 $9.15 2/15/202210,480,000 shares $106.79 million +10.0%14.3%6.8 $10.19 1/31/20229,530,000 shares $109.12 million +5.1%14.3%6.6 $11.45 1/15/20229,070,000 shares $120.45 million +19.7%13.6%6.2 $13.28 12/31/20217,580,000 shares $113.09 million +34.9%11.4%4.1 $14.92 12/15/20215,620,000 shares $86.38 million +4.7%8.4%2.7 $15.37 11/30/20215,370,000 shares $99.29 million -5.3%8.1%2.9 $18.49 11/15/20215,670,000 shares $106.99 million +19.6%8.5%3.1 $18.87 10/29/20214,740,000 shares $81.72 million +0.2%7.1%2.6 $17.24 10/15/20214,730,000 shares $77.95 million -40.7%7.1%2.8 $16.48 9/30/20217,980,000 shares $205.09 million +1.7%12.0%6.7 $25.70 9/15/20217,850,000 shares $196.25 million -6.0%11.8%9.5 $25.00 8/31/20218,350,000 shares $199.15 million -0.4%11.7%9.4 $23.85 8/13/20218,380,000 shares $179.67 million -9.6%11.7%7.5 $21.44 7/30/20219,270,000 shares $203.48 million -2.2%13.0%7.1 $21.95 7/15/20219,480,000 shares $211.88 million +0.2%13.3%7.1 $22.35 6/30/20219,460,000 shares $246.72 million +15.5%13.3%7 $26.08 6/15/20218,190,000 shares $205.00 million +3.0%11.5%7 $25.03 5/28/20217,950,000 shares $204.32 million -3.4%11.3%6.8 $25.70 5/14/20218,230,000 shares $221.72 million +13.5%11.6%7.8 $26.94 4/30/20217,250,000 shares $231.86 million -12.7%10.2%8.5 $31.98 4/15/20218,300,000 shares $266.85 million -3.8%11.9%10.1 $32.15 3/31/20218,630,000 shares $288.50 million -16.1%12.4%10 $33.43 3/15/202110,290,000 shares $395.96 million -10.9%14.6%11.1 $38.48$19 for a FULL YEAR of stock picks?! (Ad)We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $19. But why? Because there is a very small window of time... as little as 25 days from now... That will change the market forever.Click here to get in now>>> 2/26/202111,550,000 shares $378.72 million +4.2%16.5%12.4 $32.79 2/12/202111,080,000 shares $381.15 million -4.0%15.8%12.6 $34.40 1/29/202111,540,000 shares $398.25 million -15.9%16.8%12.8 $34.51 1/15/202113,720,000 shares $426.28 million +5.2%20.1%14.8 $31.07 12/31/202013,040,000 shares $347.39 million +15.7%19.1%15.4 $26.64 12/15/202011,270,000 shares $315.56 million +5.8%16.5%13.8 $28.00 11/30/202010,650,000 shares $335.69 million +0.7%15.7%14.1 $31.52 11/15/202010,580,000 shares $339.30 million +5.1%15.6%15.4 $32.07 10/30/202010,070,000 shares $358.19 million -0.5%14.9%15.5 $35.57 10/15/202010,120,000 shares $436.88 million -2.3%15.0%17.2 $43.17 9/30/202010,360,000 shares $390.68 million +1.5%15.4%17.7 $37.71 9/15/202010,210,000 shares $363.58 million -5.0%15.1%16.3 $35.61 8/31/202010,750,000 shares $383.24 million +0.6%15.9%16.6 $35.65 8/14/202010,690,000 shares $394.78 million -2.8%15.9%11.9 $36.93 7/31/202011,000,000 shares $403.37 million -8.8%16.7%9.6 $36.67 7/15/202012,060,000 shares $501.58 million -10.1%18.4%10.1 $41.59 6/30/202013,420,000 shares $561.76 million +16.8%23.3%10.9 $41.86 6/15/202011,490,000 shares $482.69 million -13.3%20.2%9.5 $42.01 5/29/202013,250,000 shares $638.12 million -1.6%23.6%10.9 $48.16 5/15/202013,460,000 shares $604.49 million +2.2%26.5%12.9 $44.91 4/30/202013,170,000 shares $380.61 million -6.7%26.0%17.4 $28.90 4/15/202014,110,000 shares $362.20 million +6.9%27.5%19.9 $25.67 3/31/202013,200,000 shares $390.72 million -0.3%26.1%19.8 $29.60 3/13/202013,240,100 shares $300.42 million +2.2%40.9%16.7 $22.69 2/28/202012,950,000 shares $246.18 million -0.5%40.0%19.8 $19.01 2/14/202013,010,000 shares $338.00 million +1.3%26.6%20.3 $25.98 1/31/202012,850,000 shares $327.03 million -1.4%26.3%21.1 $25.45 1/15/202013,030,000 shares $305.16 million +1.6%26.6%22.2 $23.42 12/31/201912,830,000 shares $300.35 million +9.6%26.2%23.8 $23.41 ALLO Short Interest - Frequently Asked Questions What is Allogene Therapeutics' current short interest? Short interest is the volume of Allogene Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 31,170,000 shares of ALLO short. Learn More on Allogene Therapeutics' current short interest. What is a good short interest ratio for Allogene Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALLO shares currently have a short interest ratio of 14.0. Learn More on Allogene Therapeutics's short interest ratio. Is Allogene Therapeutics' short interest increasing or decreasing? Allogene Therapeutics saw a decrease in short interest in the month of November. As of November 30th, there was short interest totaling 31,170,000 shares, a decrease of 11.1% from the previous total of 35,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Allogene Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Allogene Therapeutics: BioCryst Pharmaceuticals, Inc. (9.35%), Immunocore Holdings plc (14.78%), Novavax, Inc. (24.83%), Vir Biotechnology, Inc. (7.06%), Anavex Life Sciences Corp. (23.22%), Adaptive Biotechnologies Co. (6.49%), Poseida Therapeutics, Inc. (4.20%), LENZ Therapeutics, Inc. (10.15%), Immatics (6.86%), Replimune Group, Inc. (8.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Allogene Therapeutics stock? Short selling ALLO is an investing strategy that aims to generate trading profit from Allogene Therapeutics as its price is falling. ALLO shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Allogene Therapeutics? A short squeeze for Allogene Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALLO, which in turn drives the price of the stock up even further. How often is Allogene Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALLO, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies BioCryst Pharmaceuticals Short Squeeze Immunocore Short Squeeze Novavax Short Squeeze Vir Biotechnology Short Squeeze Anavex Life Sciences Short Squeeze Adaptive Biotechnologies Short Squeeze Poseida Therapeutics Short Squeeze LENZ Therapeutics Short Squeeze Immatics Short Squeeze Replimune Group Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALLO) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allogene Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allogene Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
